Compare BIO & LFUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | LFUS |
|---|---|---|
| Founded | 1952 | 1927 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Electrical Products |
| Sector | Industrials | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 6.9B |
| IPO Year | N/A | 1996 |
| Metric | BIO | LFUS |
|---|---|---|
| Price | $277.40 | $383.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $339.75 | ★ $343.33 |
| AVG Volume (30 Days) | ★ 282.4K | 212.5K |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.80% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $757,853,000.00 |
| Revenue This Year | $2.59 | $14.61 |
| Revenue Next Year | $3.21 | $7.02 |
| P/E Ratio | $9.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $149.51 |
| 52 Week High | $343.12 | $378.99 |
| Indicator | BIO | LFUS |
|---|---|---|
| Relative Strength Index (RSI) | 52.60 | 66.50 |
| Support Level | $256.85 | $241.48 |
| Resistance Level | $289.61 | N/A |
| Average True Range (ATR) | 7.87 | 13.88 |
| MACD | 1.42 | 4.84 |
| Stochastic Oscillator | 61.26 | 95.40 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Littelfuse is a primary provider of circuit protection products (such as fuses and relays) for the transportation, industrial, telecommunications, and consumer electronics end markets. The company is also increasing its power semiconductor business, where it predominantly serves industrial end markets, and is breaking into electric vehicle charging infrastructure. Littelfuse has 17,000 global employees.